A versatile, stimulus-responsive nanoparticle-based platform for use in both sonodynamic and photodynamic cancer therapy.
- Submitting institution
-
University College London
- Unit of assessment
- 12 - Engineering
- Output identifier
- 12189
- Type
- D - Journal article
- DOI
-
10.1016/j.actbio.2016.11.031
- Title of journal
- Acta Biomater
- Article number
- -
- First page
- 414
- Volume
- 49
- Issue
- -
- ISSN
- 1878-7568
- Open access status
- Compliant
- Month of publication
- November
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
https://ars.els-cdn.com/content/image/1-s2.0-S1742706116306274-mmc1.docx
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
6
- Research group(s)
-
-
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- The study led to the development of a novel biodegradable nanoparticulate system for focal ablation of tumours using combined light and ultrasound. Led to successful research grant applications: Therapeutic Acceleration Support (supported by MRC / Wellcome Trust / UCLH, GOSH, and Moorfields BRC) £74,088); Bowel and Cancer Research, £50,000 and Private donor, £118,750.
Publication led to invitations to conferences: 3rd Annual Conference of Immuno-Oncology-2020; Dalian International Conference Center, China and the 9th Annual International Symposium of Drug Delivery Systems 2020 in Amsterdam. Also the 9th International Conference of Anticancer Research, October 6-10, 2014, Sithonia, Greece.
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -